Key result
Larger necrotic core volume in STEMI is linked to ~56% higher odds of suboptimal post-fibrinolysis flow.
Why the study?
Not all STEMI patients achieve normal coronary flow following fibrinolysis, and culprit lesion plaque characteristics play a prominent role in coronary flow.
Are culprit lesion plaque characteristics assessed by VH-IVUS associated with coronary flow restoration (TIMI flow) post-fibrinolysis in patients with STEMI?
Observational (n=61)
No
Are culprit lesion plaque characteristics assessed by VH-IVUS associated with coronary flow restoration (TIMI flow) post-fibrinolysis in patients with STEMI?
Effect estimate: OR 1.561 (95% CI 1.202-2.026)
Absolute Event Rate: 8.3% vs 3.65%
p-value: p=0.001
In patients with STEMI undergoing successful fibrinolysis, a larger absolute necrotic core volume in the culprit lesion is strongly associated with suboptimal (TIMI 1-2) coronary flow restoration.
Necrotic core volume was associated with suboptimal flow post-fibrinolysis in STEMI; hypothesis-generating and requires prospective validation before clinical use.
Background Not every patient achieves normal coronary flow following fibrinolysis in STEMI (ST-segment elevation myocardial infarction). The culprit lesion plaque characteristics play a prominent role in the coronary flow before and during percutaneous coronary intervention. The main purpose was to determine the culprit lesion plaque features by virtual histology-intravascular ultrasound (VH-IVUS) in patients with STEMI following fibrinolysis in relation to baseline coronary angiogram TIMI (thrombolysis in myocardial infarction) flow. Pre-intervention IVUS was undertaken in 61 patients with STEMI after successful fibrinolysis. After the coronary angiogram, they were separated into the TIMI1–2 flow group ( n = 31) and TIMI 3 flow group ( n = 30). Culprit lesion plaque composition was evaluated by VH-IVUS. Results On gray-scale IVUS, the lesion external elastic membrane cross-sectional area (EEM CSA) was significantly higher in the TIMI 1–2 groups as compared to the TIMI 3 group (15.71 ± 3.73 mm 2 vs 13.91 ± 2.94 mm 2 , p = 0.041) with no significant difference in plaque burden (82.42% vs. 81.65%, p = 0.306) and plaque volume (108.3 mm 3 vs. 94.3 mm 3 , p = 0.194). On VH-IVUS, at the minimal luminal area site (MLS), the fibrous area (5.83 mm 2 vs. 4.37 mm 2 , p = 0.024), necrotic core (NC) area (0.95 mm 2 vs. 0.59 mm 2 , p < 0.001), and NC percentage (11% vs. 7.1%, p = 0.024) were higher in the TIMI 1–2 groups in contrast to the TIMI 3 group. The absolute necrotic core (NC) volume (8.3 mm 3 vs. 3.65 mm 3 , p < 0.001) and NC percentage (9.3% vs. 6.0%, p = 0.007) were significantly higher in the TIMI 1–2 groups as compared to the TIMI 3 group. Absolute dense calcium (DC) volume was higher in TIMI 1–2 groups with a trend towards significance (1.0 mm 3 vs.0.75 mm 3 , p = 0.051). In multivariate analysis, absolute NC volume was the only independent predictor of TIMI 1–2 flow (odds ratio = 1.561; 95% CI 1.202–2.026, p = 0.001). Receiver operating characteristic curves showed absolute NC volume has best diagnostic accuracy (AUC = 0.816, p < 0.001) to predict TIMI 1–2 flow with an optimal cutoff value of 4.5 mm 3 with sensitivity and specificity of 79% and 61%, respectively. Conclusions This study exemplifies that the necrotic core component of the culprit lesion plaque in STEMI is associated with the coronary flow after fibrinolysis. The absolute necrotic core volume is a key determinant of flow restoration post-fibrinolysis and aids in prognostication of less than TIMI 3 flow.
No takes yet. Share an insight, caveat, or question.
K et al. (2020) conducted an observational in ST-segment elevation myocardial infarction (STEMI) (n=61). TIMI 1-2 flow vs. TIMI 3 flow was evaluated on Absolute necrotic core volume (mm3) (OR 1.561, 95% CI 1.202-2.026, p=0.001). In patients with STEMI, absolute necrotic core volume was an independent predictor of suboptimal (TIMI 1-2) coronary flow restoration following fibrinolysis (OR 1.561).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: